谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Primary Results of Stimulus-MDS1: A Randomized, Double-Blind, Placebo-Controlled Phase II Study of TIM-3 Inhibition with Sabatolimab Added to Hypomethylating Agents (hmas) in Adult Patients with Higher-Risk Myelodysplastic Syndromes (MDS)

Amer M. Zeidan,Kiyoshi Ando,Odile Rauzy,Mehmet Turgut,Ming-Chung Wang,Roberto Cairoli,Hsin-An Hou,Yok-Lam Kwong,Montserrat Arnan Sangerman,Stef Meers,Vinod A. Pullarkat,Valeria Santini,Kamel Malek,Flavia Kiertsman,Jiaying Lyu,Pedro Marques Ramos,Pierre Fenaux,Yasushi Miyazaki,Uwe Platzbecker

Blood（2022）

引用 19|浏览24
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要